Reduced [Ca2+]ER protects cancer cells from apoptosis and resistance to cisplatin and taxol[58,65]; increased [Ca2+]ER, facilitated by upregulated IP3R and RyR, promotes proliferation, migration, invasion, malignancy, and apoptosis in various cancer cells[66]. Here, RYR2 is linked to cancer.